Rivas Goldstein, LLP Call : 646-859-3790

Posts tagged "Pharmacies & Pharmacists"

Can pharmaceutical companies bounce back from Novartis scandal?

Pharmaceutical giant Novartis recently reached a settlement with the Department of Justice, Securities Exchange Commission and U.S. Attorney for the Southern District of New York regarding various claims of criminal wrongdoing. The allegations include claims the group violated the False Claims Act (FCA) and Anti-Kickback Statute (AKS). Essentially, the government claimed the group gave health care providers various incentives in exchange for using and prescribing their products.

NY pharmacist charged with health care fraud and tax crimes

New York officials recently charged a local pharmacy owner of Anti-Kickback Statute (AKS) violations and tax crimes. Prosecutors claim the man, along with others associated with the pharmacy, began illegally bribing doctors to use their pharmacy for services in 2010. In addition to cash payments, the government claimed the accused offered expensive meals and lavish gifts to entice doctors and doctors' employees in New Jersey and New York to send prescriptions to their facility.

Pharmacies: 3 lessons from Walgreens' evolution in 2019

The giant, nationwide pharmacy Walgreens went through many changes in 2019. The year began with a new partnership with Microsoft to help better ensure the pharmacy was up to date on technological innovations for health care delivery as well as retail innovations. The company also made additional investments in digital health throughout the year.

Pharmacy owner accused of bribing doctors: 3 lessons

The government continues to crackdown on allegations of health care fraud. One recent example involves a pharmacist accused of various crimes. According to the complaint, the prosecution has charged the pharmacy owner with two crimes. The first is conspiracy to commit health care fraud and the second conspiracy to pay illegal kickbacks to a physician.

New crackdown targets Medicaid-unapproved drug reimbursements

Several pharmaceutical companies intentionally misrepresented the degree to which certain drugs and other items were reimbursable under Medicaid, according to the attorney general of another state. The drugs and medical devices were marketed to the state and health care providers as covered outpatient drugs despite being unapproved by the U.S. Food and Drug Administration, the AG alleges, and these fraudulent marketing practices resulted in big gains in market share for the companies.

Email Us For A Response

Schedule A Consultation With An Attorney

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Austin Office
3345 Bee Cave Rd, Suite 104
Austin, TX 78746

Phone: 512-481-2916
Map & Directions

New York Office
By Appointment Only
405 Lexington Ave 26th Floor
New York, NY 10174

Phone: 646-859-3790
Map & Directions

New Jersey Office
By Appointment Only
1 Gateway Center, Suite 2600
Newark, NJ 07102

Phone: 646-859-3790
Map & Directions

Review Us